POINT Biopharma Global Inc., (PNT): Price and Financial Metrics
PNT Price/Volume Stats
| Current price | $12.50 | 52-week high | $14.35 |
| Prev. close | $12.48 | 52-week low | $6.57 |
| Day low | $12.49 | Volume | 3,290,900 |
| Day high | $12.51 | Avg. volume | 1,442,213 |
| 50-day MA | $13.22 | Dividend yield | N/A |
| 200-day MA | $9.79 | Market Cap | 1.33B |
PNT Stock Price Chart Interactive Chart >
POINT Biopharma Global Inc., (PNT) Company Bio
POINT Biopharma Global Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of radioligand therapies for the treatment of cancer. Its products include PNT2001, a PSMA radioligand that is in preclinical studies for early stage prostate cancer treatment; PNT2002, which is in Phase 3 studies to evaluate superiority to the standard of care in mCRPC patients; PNT2003, a somatostatin-targeted radioligand therapy that is in Phase 3 trials for the treatment of patients with somatostatin receptor-positive neuroendocrine tumors; and PNT2004, a radioligand that targets fibroblast activation protein-a. The company is based in Indianapolis, Indiana.
PNT Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | -8.05% |
| 3-year | 43.02% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | 30.18% |
| 2021 | -59.77% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...